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ABSTRACT 
 
Taenia solium cysticercosis is a neglected zoonotic disease that constitutes a serious 
public health problem in many low-income countries of Latin America, Africa, and 
Asia. Although diagnostic antigens are available, it is still necessary to identify new 
targets to improve the current diagnostic methods. Diagnostics tests are expensive, and 
most of them require the use of specialized equipment. Here, an expressed sequence tag 
(EST) library consisting of 5,760 sequences from T. solium cysticercus was constructed 
in which 1,650 unique sequences were identified, 845 of them previously unknown. 
Also, 2-DE was performed and succeeded in detecting several immunogenic proteins, 
among which TsolHSP36 and Tsol-p27 were identified by liquid chromatography-mass 
spectrometry (LC-MSMS), and Tsol-p27 was also found in our constructed EST 
library. A recombinant version of Tsol-p27 was produced and analysed by Western 
blotting, and it was recognized by sera from 13 NCC-positive humans but not by sera 
from control subjects. To develop a new and inexpensive diagnostic test that offers high 
sensitivity and specificity, we evaluated an immunodot blot assay using the previously 
analysed Tsol-p27 protein. The efficacy of the method was studied in comparison with 
the effectiveness of ELISA and of Western blot formats using the antigens TsolHSP36 
and Tsol-p27. Compared to Western blot Tsol-p27, immunodot blot Tsol-p27 offered 
similar specificity (97.8% vs. 95.6%) but better sensitivity (86.7% vs. 76.4%). Also, 
sensitivity and specificity results were similar when comparing the ELISA and 
immunodot blot Tsol-p27 methods, and were lowest for Western blotting with 
TsolHSP36 (61.9% and 86.1%, respectively). Localization of Tsol-p27 was determined 
by immunohistochemistry using anti-rabbit Tsol-p27. Antibody response was observed 
in the parenchymal fold and tegument of the spiral canal. Sequencing analysis revealed 
that Tsol-p27 belongs to a group of proteins with the same bin/amphiphysin/rvs (BAR) 
domain as endophilin-B. This finding suggests that Tsol-p27 has functions related to 
membrane sorting, fusion, and transport, and that it may also aid growth of the parasite 
and support the adult tapeworm during colonization of the human intestine.   
 
In conclusion, the present results show that the immunodot blot Tsol-p27 assay has 
good sensitivity and specificity, and it would be easy to implement this test in poorly 
equipped laboratories in endemic countries. Furthermore, this method is less expensive 
than ELISA and EITB analysis. 
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1  INTRODUCTION 
 
1.1 GENERAL BACKGROUND 
Taenia solium cysticercosis is a zoonotic disease that is often overlooked, even though 
it has serious public health consequences in many low-income countries in Latin 
America, Africa, and Asia. Indeed, cysticercosis is one of the NTDs, a group of 
chronic, debilitating, and poverty-promoting infections that are caused primarily by 
parasites, bacteria, and also some viruses and fungal species, and mainly affect the 
poorest people living in countries with low socioeconomic status [1].  
 
The NTDs are known as infections of poverty because of their impact on child 
development, pregnancy outcomes, and worker productivity [1]. It has been estimated 
that 40% of the 556 million people living in the LAC region live below the poverty 
line, and 47 million of those individuals have to manage on less than 1 USD per day 
and another 74 million on less than 2 USD per day [2]. Cysticercosis is endemic in low-
income countries, where transmission is associated with pigs raised in close contact 
with humans and poor hygiene and sanitary conditions. 
 
The current methods used to diagnose human NCC include neuroimaging tests (i.e., 
MRI and CT), followed by a confirmatory serological method. Neuroimaging 
techniques are expensive and are seldom available to the majority of the population in 
endemic regions. Other diagnostic tools include histological identification of parasites 
in biopsies or CSF and immunological methods. Among the latter, ELISA and EITB 
assays are used most often to diagnose human cysticercosis [3], and both those 
techniques are specific and sensitive. However, they have the disadvantage of requiring 
expensive, specialized equipment that must be run by trained technicians, which limits 
the use of ELISA and EITB in poorly equipped laboratories in endemic countries. Thus 
there is a continuing need for alternative diagnostic methods that are practical, 
reproducible, and economical, and also reduce the amount of crude material required 
for analysis [4-6]. 
 
Cysticercosis is also an emerging disease in some high-income nations as the result of 
international travel and immigration from endemic areas [7]. Furthermore, infection 
with the pork tapeworm still represents a public health issue in endemic countries, 
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because thousands of infective T. solium eggs are released from humans and give rise 
to NCC, the main clinical form of cysticercosis [8]. This disease has been seriously 
neglected due to the lack of information and understanding of the problem in many 
countries.  
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2 BIOLOGY OF TAENIA SOLIUM 
 
2.1 LIFE CYCLE 
In the life cycle of T. solium, humans are the definitive host for the adult tapeworm, and 
pigs are the intermediate host for the cysticercus (Fig. 1). Humans harbour adult 
tapeworms, and eggs from the parasite are spread to the environment in faeces from the 
host. When a human ingests undercooked pork containing a cysticercus, the larva 
evaginates, attaches itself to the host’s duodenal wall, and develops into an adult 
tapeworm. The adult worm attaches itself to the intestinal mucosa by means of a scolex 
equipped with four lateral suckers and a rostellum that bears 25–50 hooklets. 
Thereafter, the adult tapeworm grows and produces hundreds of hermaphroditic 
proglottids, which differentiate into gravid proglottids that are full of infective eggs. 
The eggs are spherical and measure 30–40 µm in diameter [9].  
 
 
Figure 1. Life cycle of T. solium [8]. 
 
The fertilized eggs detach daily from the adult tapeworm and are expelled into the 
environment by passive discharge in the host’s faeces. These eggs may in turn 
contaminate the soil and vegetables and other food prepared under deficient sanitary 
conditions. After being liberated from the proglottids, the eggs can be ingested by pigs 
and humans. Once they reach the digestive tract of the host, the eggs lose their coat 
through the digestive effects of the gastric and pancreatic enzymes, and they are 
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liberated as hexacanth embryos or oncospheres. Thereafter, the oncospheres cross the 
intestinal wall, enter the systemic circulation, and are transported to various organs in 
the host, including skeletal muscles, the CNS, and subcutaneous tissues. In those 
locations, the oncospheres acquire a vesicular shape and become cysticerci over a 
period of two months. The life cycle of the parasite is completed when undercooked 
pork containing cysticerci is ingested by a new human host [10-11]. 
 
Development of the larval stage of T. solium can also occur in the carrier of an adult 
tapeworm through what is called exogenous autoinfection. This involves ano-oral 
contamination and endogenous autoinfection in which eggs from the adult tapeworm 
living in the small intestine return to the stomach as the result of reverse peristalsis. 
Lack of hygiene and living with carriers of adult tapeworms are recognized as high risk 
factors for contracting cysticercosis [12-13]. 
 
2.2 TAENIA SOLIUM MORPHOLOGY 
Adult tapeworm: The adult tapeworm stage of T. solium is specific to the human host 
and has not been found in other species under natural conditions. The adult tapeworm is 
flat, cream coloured, and segmented, and it can be up to 8 m long and lives in the small 
intestine of the host [14]. Morphologically, the tapeworm is composed of a head or 
scolex that is 1 mm in diameter and equipped with four muscular suckers for 
attachment. The suckers contain an armed rostellum bearing a double row of 22 to 36 
hooks. Behind the scolex is a thin, poorly differentiated neck that is approximately 5 to 
10 mm long and consists of germinative tissue that shows biokinetic activity; it is from 
this part of the worm that the entire body or strobila is formed. The strobila is made up 
of 400–800 segments known as proglottids, which are covered by a tegument that 
forms the absorption surface through which the adult tapeworm ingests metabolites 
from the host [10, 15-16]. The strobila comprises immature, mature, and gravid 
proglottids, and those that are immature are undifferentiated and located closest to the 
neck. Mature proglottids contain male and female genitalia, and self- or cross-
fertilization occurs after 2 or 3 months. Gravid proglottids are located at the tail end of 
the adult tapeworm, and each one contains a branched uterus packed with infected eggs 
that are embryos, also called oncospheres, and these are shed into the environment with 
the faeces of the adult tapeworm carrier [14, 17]. 
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Oncospheres: An oncosphere in the adult tapeworm uterus is 29 to 77 µm in diameter 
and consists of an embryo that is enclosed within a chorionic membrane, an 
embryophore, an embryophore membrane, and two oncosphere membranes. The 
oncosphere is also referred to as a hexacanth embryo, because it has three pairs of 
hooks [14].  
 
Cysticercus: The larval stage or “Cysticercus cellulosae” is an ovoid translucent 
vesicle that is 0.5 to 2.0 cm in diameter. It is filled with in a colourless liquid and 
contains an invaginated scolex (larval head) that is equipped with four suckers and an 
armed rostellum with two rows of hooks. The wall of the bladder is a membranous 
structure composed of three layers: a cuticle or external layer, a cellular or middle 
layer, and a reticular or internal layer [18]. The morphology of the cysticercus can vary 
and include an irregular form know as a “racemose cysticercus”, which looks like a 
large round or lobulated bladder, or a cluster of grapes. The racemose form lacks a 
scolex and can be up to 10–20 cm in size and contain several millilitres of vesicle fluid 
[19].  
 
The cysticercus parenchyma consists of a complicated system of cells, slits, fibres, and 
channels that permits invagination of the scolex. The invaginated scolex forms a spiral 
canal, and the suckers are located at the end of the canal from which the armed 
rostellum arises. When a cysticercus is exposed to trypsin or bile in vitro, the larva 
evaginates in a process involving emergence of the scolex from the spiral canal. It is 
assumed that the evagination in vivo releases the scolex into the host’s duodenum and 
promotes attachment to the intestinal wall of the definite host [15]. The surface of the 
larva is a syncytial tegument that is covered with digitiform projections called 
microtriches that allow the parasite to absorb nutrients from the interstitial tissue of the 
host. The cysticercus is an acoelomate and lacks a digestive system, and thus it must 
have an intact tegumentary surface in order to survive [15, 20]. 
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3 CLINICAL IMPORTANCE OF TAENIASIS AND 
HUMAN CYSTICERCOSIS  
 
3.1 TAENIASIS 
The condition called taeniasis arises when an adult tapeworm resides in the lumen of a 
human intestine, and it occurs only in human hosts. From the perspective of disease 
prevention, this is an important advantage, because the infected humans become the 
central target for any control/elimination action at a population level. Most adult 
tapeworm carriers are asymptomatic, although some present with minor symptoms of 
abdominal pain, distension, nausea, and diarrhoea, and some note the passage of 
proglottids in their faeces [21-22].  
 
Two drugs are commercially available for the treatment of adult tapeworm infections: 
praziquantel and niclosamide. Niclosamide is the best choice, because it is not absorbed 
from the intestinal lumen [23].  
 
3.2 HUMAN CYSTICERCOSIS 
Cysticerci can become established in a wide of range of locations, including 
subcutaneous tissue, skeletal muscle, myocardium, the eyes, and the CNS. 
Subcutaneous cysticercosis entails the typical larvae in nodules that are painless for the 
host but surrounded by varying degrees of inflammation. Ocular cysticercosis can 
involve the subconjuntival space, extraocular muscles, aqueous or vitreous humour, the 
subretinal layer, or the optic nerve. In this disease, NCC is the most important clinical 
feature and occurs a larva is established in the brain. NCC in the CNS gives rise to 
symptoms through various mechanisms, such as local damage, inflammation, direct 
compression, blocking of CSF circulation, and vasculitis [23-24].     
 
NCC entails infection of the brain by the larval stage of T. solium. NCC is the most 
common cause of acquired epilepsy in many low-income countries and accounts for 
over 20 million cases and 50 000 deaths each year. The clinical manifestations depend 
on the number, size, stage, and localization of the cysticerci. Seizures are the most 
common manifestation, occurring in 50% to 80% of patients [23, 25-26]. 
 
   7 
A cysticercus can reside in different intracranial and intracranial-spinal compartments. 
In the brain parenchyma, a cysticercus progresses through four phases called the 
vesicular, colloidal, granular-nodular, and calcified stages [27].  
 
In the initial vesicular stage, the viable larva is surrounded by a clear fluid, and the 
affected human is asymptomatic. The colloidal stage arises during prolonged 
degeneration of the cysticercus, and it can induce an inflammatory reaction in the host. 
As the process of degeneration continues, the cysticercus starts to mineralize, most 
likely as the result of some degree of persistent inflammation, and thereby forms the 
granular-nodular stage. Finally, the granulation tissue is replaced by collagenous 
structures and calcification to produce the nodular calcified stage. All three of the 
degenerating stages can cause seizures in the host, and the colloidal stage can 
occasionally produce symptoms and signs of a mass lesion that raise the ICP. If there 
are numerous cysticerci in the brain, degeneration of the larvae can lead to severe 
oedema and markedly elevated ICP, which can cause headache, vomiting, altered 
sensorium, and death. This form of disease is termed cysticercotic encephalitis [25, 28].  
 
Extraparenchymal NCC occurs when cysticerci enter the ventricular system where they 
cause hydrocephalus by blocking circulation of the CSF. The cysticerci can also settle 
in the subarachnoid spaces at the base of the brain or in the sylvian fissures, where they 
lose their scolices and creep along the subarachnoid spaces; this form of the parasite is 
called a racemose cysticercus. The symptoms associated with this condition are related 
to the severe inflammation of the vessels in the subarachnoid spaces, which is caused 
by the cysticerci and leads to infarction of the brain stem and the basal ganglia [29].  
 
The treatment of NCC has advanced with the advent of the two drugs praziquantel and 
albendazole. Use of these agents should be individualized according to the immune 
response of the patient and the number, type, size, location, and stage of development 
of the cysticerci. Indiscriminate or unsupervised use can cause side effects, including 
dizziness, hepatic dysfunction, brain infarction, and death due to acute intracranial 
hypertension syndrome [30-31]. 
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4 EPIDEMIOLOGY 
 
Cysticercosis is a global disease that occurs primarily in low-income countries where 
pigs are raised and pork is consumed, and poor hygiene and sanitary conditions allow 
these animals to be exposed to human faeces. Epidemiological studies have 
demonstrated that cysticercosis is endemic in most countries in Latin America, Africa, 
and Asia (Fig. 2) [7, 32]. Latin American countries with prevalent cysticercosis include 
the following: Mexico [12], Guatemala [33], Honduras [34], Nicaragua [35-36], 
Bolivia [37], Peru [38], Ecuador [39], Colombia [40], Venezuela [41], and Brazil [42]. 
Cysticercosis is also an emerging disease in some high-income nations as the result of 
travel to or immigration from endemic areas [7]. 
 
 
 
Figure 2. Map showing the global distribution of taeniasis and T. solium cysticercosis in humans. Dotted 
lines on maps represent approximate border lines for which there may not yet be full agreement. 
[http://gamapserver.who.int/mapLibrary/ Files/Maps/Global_cysticercosis_2009.png; accessed January 
2012]. 
 
It has been estimated that at least 50 million people in the world suffer from epilepsy, 
and more than 80% those individuals live in low-income countries. NCC is the most 
common cause of acquired epilepsy in many low-income nations and the most common 
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parasitic infection of the human nervous system, and it causes approximately 50,000 
deaths each year [26, 43]. 
 
In Latin America, approximately 75 million people are at risk of NCC, and 400,000 are 
symptomatic [44]. The annual incidence of taeniasis has been reported to be from 10 to 
50 million cases in humans and 50 million cases in pigs [45-46]. It has been proposed 
that T. solium cysticercosis should be declared an international reportable disease, 
which may not seem necessary considering that cysticercosis does not lead to sudden 
large-scale international outbreaks. However, T. solium cysticercosis belongs to the 
group of NTDs, and it is an indicator of poverty around the world [26, 47]. The social 
consequences of NCC are related chiefly to the seizures caused by the disease and 
include stigmatization and incapacitation leading to decreased productivity. In endemic 
countries, NCC affects older children and adults, which has a serious economic impact 
due to expected disability [48]. It has estimated that annual work productivity is 
reduced by up to 30% in people with NCC-induced epilepsy [49]. Porcine cysticercosis 
also has a significant economic impact, causing annual losses of 164 million USD in 
Latin America and approximately 25 million euros in ten Western and Central African 
countries [50-51]. 
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5 DIAGNOSIS 
 
5.1 TAENIASIS 
Diagnosis of T. solium infection is based on a combination of comparative morphology, 
immunodiagnostic tests, and molecular methods. Macroscopic diagnosis of taeniasis is 
achieved through detection of T. solium eggs in human faeces, but this test offers only 
low specificity and sensitivity of 22.5% and 56%, respectively [52-53]. One 
disadvantage of this diagnostic procedure is that the eggs of T. solium and T. saginata 
are morphologically similar, and thus it is necessary to collect the adult tapeworm or 
proglottids to identify the species on the basis of morphological characteristics. T. 
solium is recognized by the presence of three ovarian lobes and the absence of a vaginal 
sphincter in mature proglottids, and the presence of 7–16 unilateral uterine branches in 
gravid proglottids [54-55]. 
 
The capacity to diagnose adult tapeworm carriers increased dramatically with the 
development of an ELISA test for Taenia-specific coproantigens in faecal samples [33, 
52, 55]. A Western blot assay has been developed that uses coproantigens of adult T. 
solium to detect specific antibodies in serum, and this method has been found to 
provide 95% sensitivity and 100% specificity, levels that are much better than those 
achieved by microscopy and comparable to those of coproantigen ELISA [56-57].  
 
Several specific molecular methods have been developed to detect DNA in human 
faeces for diagnosis of taeniasis. Molecular approaches include PCR, PCR combined 
with RFLP analysis, and multiplex-PCR [54, 58]. These techniques are highly sensitive 
and species-specific, thereby overcoming the limitations of other diagnostic tests. 
However, high cost and lack of technical capacity for handling these molecular 
methods limit their use in T. solium-endemic countries.  
 
5.2 HUMAN CYSTICERCOSIS 
It can be difficult to diagnose human cysticercosis and NCC due to the lack of specific 
signs and symptoms of these diseases. NCC is diagnosed chiefly by neuroimaging 
techniques such as CT or MRI and confirmed serology. Immunodiagnostic methods 
can be divided into two main groups: those that use an antigenic mixture or single 
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antigens to detect antibodies against them, and those that use specific antibodies to find 
specific antigens in the samples [59-61]. 
 
5.2.1 NEUROIMAGING METHODS 
CT and MRI are used to identify cysticerci in the brain not only to confirm the 
aetiology of the diseases, but also to provide information on the number, localization, 
size, and stage of the larvae. CT can detect most cases of NCC, with exception of small 
lesions in the ventricles or basal cisterns. MRI is considered to be more accurate than 
CT for assessing the intensity of the infection and the location and stage of a 
cysticercus [23, 62]. Neuroimaging findings can be classified as consistent with NCC, 
or they can establish either a probable or definitive diagnosis of the disease [63]. The 
clinical findings indicating NCC are roundish cysticerci that are 1–2 cm in diameter, 
have smooth walls, and contain an eccentric dot (scolex). The presence of multiple 
lesions compatible with NCC is useful in confirming the disease [8].   
 
5.2.2 ANTIBODY-DETECTING METHODS 
Infection with T. solium results in a response involving production of specific 
antibodies, which can be detected in serum, CSF, saliva, and tears [4]. The following 
are examples of the antigens that have been used to diagnose human cysticercosis: 
LMM antigens [64], ES antigens [64-65], CSE [64, 66], total saline extract [67], 
LLGPs [68], vesicular fluid [66], membrane and scolex extracts [66], recombinant 
proteins [6, 35], and synthetic peptides [69-70].  
 
Several techniques for detecting antibodies in humans have been described, including 
radioimmunoassay, haemagglutination, the complement fixation test, dipstick assays, 
latex agglutination, ELISA, Western blot analysis, and immunodot blot assay [3, 35, 
60]. Detection of antibodies is confirmatory rather than decisive, and can indicate prior 
exposure to infection and not necessarily current active infection with viable cysticerci. 
EITB analysis and ELISA are the antibody detection tests most frequently used to 
diagnose cysticercosis [71-72]. EITB has been reported to have 98% sensitivity and 
100% specificity, although the sensitivity drops considerably in cases involving single 
cysts in the brain. This technique requires expensive reagents and advanced equipment, 
as well as trained staff to perform the test [73]. The antibody-detecting ELISA provides 
sensitivity and specificity similar to EITB, and use of recombinant antigens in ELISA 
format has been found to give 90% sensitivity and 100% specificity [74]. A limitation 
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of serological studies based on antibody detection is that active disease can be 
overestimated due to occurrence of a transient antibody response, which can be the 
result of exposure to T. solium eggs that do not develop into a viable infection. The 
antibody reaction may persist long after the parasites have been eliminated by an 
immune mechanism or drug therapy [60, 75].  
 
Another tool has emerged for diagnosing human cysticercosis, which is not considered 
to be an immunodiagnostic method. This technique is based on PCR amplification of T. 
solium DNA present in the CSF of NCC patients, and it has been reported to provide 
high sensitivity (96.7%) [76].  
 
Inasmuch as the EITB method is expensive and requires skilled technicians to run it, 
various other techniques have been implemented to diagnose NCC. One of these is the 
immunodot blot assay, which is easier to perform and cheaper, and has been shown to 
provide levels of sensitivity and specificity similar to those obtained by ELISA [35, 77-
78].  
 
5.2.3 ANTIGEN-DETECTING METHODS 
Samples of serum or CSF are used most frequently to detect antibodies against parasite 
antigens, and several assays employing either polyclonal or monoclonal antibodies 
have been developed for that purpose. The immunoglobulin used most often is IgG, 
because it is the predominant antibody detected in NCC; IgA, IgE, and IgM can also be 
detected in NCC patients but are of little diagnostic value [59].   
 
Antigen-detecting methods that use mAbs against the related parasite species T. 
saginata have been developed. Two such techniques are ELISAs based on the mAbs 
HP10 and B158/B60, which have been validated and used routinely to detect parasite 
antigen [3, 79-80]. These two tests can identify patients with a viable NCC infection, 
but they are not as sensitive as antibody assays based on Western blot analysis [80-83]. 
 It may be more appropriate to use CSF samples to diagnose NCC, since the cysticerci 
are located in the brain in this disease. However, sampling of CSF is more invasive and 
entails greater risks compared to blood sampling. Results of antigen ELISA will 
become negative three months after a successful treatment [83-84]. Considering the 
drawbacks of antibody-detecting systems in the clinical setting, it may be advisable to 
   13 
instead use antigen detection to confirm the presence of live parasites, which may aid 
decisions regarding the use of anti-parasite treatment [79].  
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6 PREVENTION AND CONTROL 
 
T. solium has a high reproductive potential, and it is plausible that an adult tapeworm 
can expel over 100,000 infective eggs each day. Moreover, cysticercosis is related to 
poverty, and hence costs and locally available resources should be taken into 
consideration in all strategies aimed at controlling this disease [14, 55]. 
 
Cysticercosis is considered to be potentially eradicable, because it involves a single 
definitive host. The human carriers of adult tapeworms represent the only source of 
infection for pigs, and the pigs constitute the only viable intermediate host. In addition, 
there is no major role of a wild cycle in the transmission of T. solium [85].  
 
The main obstacles to eradication of cysticercosis are the following: the need for 
simpler methods for diagnosing the disease in humans and pigs; the limited availability 
of drugs for treating taeniasis and porcine cysticercosis in endemic areas; a general lack 
of awareness of the presence and impact of the disease in the affected communities. 
There are also other factors that contribute to perpetuation of the disease, such as the 
fact that most endemic communities have deficient sewage systems and latrines, and 
inefficient inspection to detect infected pork in slaughterhouses [35, 55]. 
 
The following measures are among those used to control taeniasis/cysticercosis: 
detection and treatment of infected carriers of adult tapeworms [9]; mass treatment with 
niclosamide or praziquantel in the human population; health education; targeted or 
mass treatment of pigs with oxfendazole; ensuring that pigs do not come in contact with 
infected faeces [39, 55, 86-87].  
 
Another important component in the control of taeniasis/cysticercosis is potential 
development of vaccines, which could be used in three different ways to directly or 
indirectly reduce human NCC: humans could be vaccinated to prevent infection with 
cysticerci or against adult tapeworms, or pigs could be immunized against T. solium 
cysticercosis. Development of a vaccine to protect humans from cysticercosis would be 
directly beneficial, but production costs in that context would be extremely high [88]. 
Also, prevention of porcine T. solium cysticercosis would remove the source of 
infections with adult tapeworm in humans and therefore lead indirectly to a reduction in 
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the incidence of human NCC. The vaccine antigens that have shown promise in 
experimental trials were derived from T. solium oncospheres [89-90]. Also, three host-
protective recombinant antigens designated To16, To18, and To45W were discovered 
in Taenia ovis [91-92] and have been used to gain knowledge regarding the 
development of oncosphere antigen-based vaccines against other related parasites [93]. 
Later, three homologues of To16, To18, and To45W were identified and cloned from 
T. solium [94-96]. The antigens Tsol16, Tsol18, and Tsol45 have been effective in 
inducing high-level (> 97%) protection in pigs, although thus far Tsol18 has proven 
most effective [88]. It is possible that the recently discovered Tsol15, which is a 
homologue of To45W, will be added to this group of antigens and tested as a possible 
diagnostic target or candidate vaccine for human or porcine cysticercosis [5].  
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7 AIMS   
 
The specific aims of the research underlying this thesis were as follows: 
 
 To analyse an EST library from T. solium cysticercus.  
 
 To identify immunoreactive proteins from T. solium cysticerci. 
 
 To develop and validate an immunodiagnostic test for human cysticercosis 
 
 To localize the diagnostic antigens Tsol-p27 and TsolHSP36 in T. solium 
cysticercal tissue. 
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8 MATERIALS AND METHODS 
 
8.1 LABORATORY PROCEDURES  
This section briefly describes the general study design, the collection of serum samples, 
and the experimental procedures performed in the present research. Detailed 
information about the materials and methods can be found in the corresponding papers.  
 
8.1.1 SERUM SAMPLE COLLECTION 
Paper II: Human serum samples confirmed positive for NCC by computer tomography 
were used to identify immunoreactive proteins. Preliminary evaluation was performed 
on samples from two groups of subjects: a positive control group comprising four 
patients with NCC confirmed by CT and ELISA (Cypress) and nine patients with 
positive serology by ELISA (Cypress), and a healthy control group consisting of 13 
apparently healthy humans.  
 
Paper III: To study the efficacy of an immunodot blot test using the Tsol-p27 protein, 
a total of 100 human serum samples were collected from epileptic patients who 
attended the health centres of the Departments of Chinandega and Rosita in Nicaragua 
between March and August 2010. Sixty serum samples with positive (30 sera) or 
negative (30 sera) IF serology for Chagas disease were also included. 
 
8.1.2 BIOINFORMATIC AND MOLECULAR METHODS 
Transformation and excision (Paper I): This study used a cDNA library, Uni-ZAP 
XR (Stratagene), constructed from polyA+ selected mRNA from 1.75 g of cysticerci 
isolated from muscle of a naturally infected Peruvian pig (kindly provided by Kathy 
Hancock, [CDC], Atlanta, GA, USA) [97]. The library was transformed into the 
ampicillin-resistant vector phagemid pBluescript SK (+/-) and host bacteria (XLOLR) 
by applying a mass excision protocol as described by the manufacturer (ZAP Express 
cDNA Synthesis Kit and ZAP Express cDNA Gigapack III Gold Cloning Kit, 
Instruction Manual, Stratagene) [5].  
 
Preparation and sequencing (Paper I): Positive, colourless bacterial colonies were 
selected and placed in 96-well microtitre plates and sequenced using a Megabace 1000 
sequencing system (Amersham Bioscience) [5].  
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Assembly, sequence analysis, and signal peptide prediction (Paper I): 
Computational analyses were performed using Phred for base calling and Phrap to 
assemble sequences. Cross-matching was done to achieve queries within the EST 
library, to cut out vector sequences, and to assemble contigs [98-99]. To compare the 
generated ESTs with databases on both a protein and a gene level, BLAST searches 
were conducted at the NCBI (Bethesda, MD, USA). To exclude irrelevant or low 
BLAST scores, a cut-off E-value of < 10
–5
 was used. Translation of the DNA 
sequences into three different frames was performed using Virtual Ribosome version 
1.1 [100].To detect signal peptides, the D-score in the implemented neural network was 
applied together with Hidden Markov models [5].  
 
Taxonomic classification (Paper I): For all the unique sequences, the most probable 
putative protein of each contig and singlet was assigned to one of seven different 
hierarchic taxonomic categories. In short, based on the BLAST results, the organisms 
producing the putative proteins were assigned to the taxonomic group closest related to 
T. solium, and BLAST scores with E-values < 10
–5
 were classified as unknowns [5]. 
 
Gene annotation (Paper I): The software Blast2GO was used as described earlier 
[101]. Sequences in FASTA format were loaded into the program, and the default 
settings were used to assign GO terms. From a BLAST search, the annotation of the 
sequences was performed and pie charts were made using 2
nd
 level GO terms based on 
biological processes, molecular functions, and cellular components [5]. InterProScan 
was also used in the Blast2GO software, and results merged with the GO terms, as 
described elsewhere [101]. In addition, analysis of metabolic pathways also performed 
using Blast2GO together with KOBAS [102-103] and the KEGG database [101]. 
 
Cloning, expression, and purification of Tsol-p27 and TsolHSP36 (Paper II): The 
selected cDNA used to produce the recombinant Tsol-p27 and TsolHSP36 proteins was 
amplified using specific primers. The PCR products of the Tsol-p27 and TsolHSP36 
genes were subcloned in Bam HI/Xho1 and Bam HI/Eco R1 sites of the expression 
plasmid vector pGEX-4T-1 (Amersham Pharmacia) downstream of GST. Papers II–
IV: Recombinant GST fusion proteins were expressed in E. coli BL21 (Invitrogen) 
after induction with 1 mM IPTG (Sigma). The soluble recombinant proteins were 
purified using magnetic beads coated with glutathione and PreScission Protease (GE 
Healthcare) according to the manufacturer’s instructions. Paper III: In addition to the 
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purification step with glutathione-agarose beads, Tsol-p27 antigen was further purified 
using his-selected nickel magnetic beads (Sigma) [6, 35].  
 
Sequencing of immunoreactive proteins (Paper II): Spots that were recognized by 
positive human sera in the 2-DE Western blotting and identified in the 2-DE gel stained 
with Coomassie Brilliant Blue (Bio Rad) were manually cut out and stored at –20 °C 
until used. Native proteins were trypsinized, and five to 10 fragments were identified 
by LC-MSMS [6].  
 
Isolation of cDNA encoding Tsol-p27 and TsolHSP36 (Paper II): The amino acid 
sequences corresponding to Tsol-p27 were found by searching our previously 
constructed EST library for T. solium cysticercus [5], and the sequence corresponding 
to TsolHSP36 has been described elsewhere [104].  
 
DNA and amino acid sequencing analysis of Tsol-p27 (Paper II): The ESTs were 
translated in silico using Virtual Ribosome version 1.1, and the resulting sequences 
served as an in silico library of translated ESTs. Amino acid sequences of peptides 
derived from Tsol-p27 were identified, and the corresponding ESTs were isolated and 
sequenced. DNA sequencing was done using a MegaBace 1000 system (Amersham 
Biosciences). Papers II and IV: The sequencing analysis of Tsol-p27 was performed 
at NCBI using a BLAST search option with a cut-off E-value of 10
–5
 [6]. Paper IV: To 
be able to describe the family domain corresponding to Tsol-p27, a cut-off of 10
–9
 was 
employed in the search option.  
 
2-DE Western blotting (Paper II): Immunoreactive proteins in T. solium cysticerci 
were identified by 2-DE Western blotting [6]. Samples were analysed in triplicate to 
assess the reproducibility of the protein patterns. The gels were either stained with 
Coomassie Brilliant Blue (Bio Rad) or blotted onto nitrocellulose membranes (GE 
Healthcare). 
 
8.1.3 IMMUNODIAGNOSTIC METHODS 
EITB (Paper III): EITB was performed according to the procedure recommended by 
the manufacturer (LDBIO Diagnostic, Lyon, France)[35]. 
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Western blot analysis: The proteins separated by 2-DE (Paper II), the recombinant 
Tsol-p27 and TsolHSP36 antigens (Papers III and IV), and the extracts of adult 
tapeworm and cysticerci (Paper IV) were analysed by Western blotting. The 
experimental procedures are described in the respective papers [6, 35]. 
 
Antibody-detecting ELISA (Paper III): A commercial ELISA (Cypress) was used 
according to the manufacturer’s instructions [35].  
 
Immunodot blot analysis of Tsol-p27 (Paper III): Immunodot blot analysis was 
carried out as described elsewhere [35].  
 
8.1.4 IMMUNOHISTOCHEMISTRY ANALYSIS 
Production of rabbit polyclonal serum (Paper IV): The recombinant Tsol-p27 and 
TsolHSP36 were used to raise polyclonal antibodies in rabbits. On days 0, 28, 56, and 
84, two male rabbits per antigen received four immunizations with the recombinant 
proteins (250 µg/rabbit) emulsified in 250 µl of Freund’s complete (first immunization) 
or incomplete (second to fourth immunization) adjuvant. Serum samples collected 
before immunizations were used as negative control. Serum was separated and stored at 
–20 °C until used. 
 
Localization of Tsol-p27 and TsolHSP36 in T. solium cysticercus (Paper IV): The 
anti-rabbit Tsol-p27 and TsolHSP36 immune sera were also used to localize the Tsol-
p27 and TsolHSP36 proteins in T. solium cysticercal tissue. 
  
Phylogenetic analysis (Paper IV): Multiple sequence alignments of proteins of the 
endophilin-B family were performed according to the ClustalW method [105]. The 
protein sequences were obtained from GenBank. A phylogenetic tree was constructed 
with the aid of the software Lasergene 9 (DNASTAR Inc., Madison, WI, USA). 
Confidence values were assessed from 1,000 bootstrap replicates of the original 
sequences data.  
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Papers II and III: Collection and analysis of serum samples were approved by the 
Ethics Committee of the Faculty of Medical Science at National Autonomous 
University of Nicaragua, León, Nicaragua (Permission nos. 5, 47, and 73).  
 
Paper IV: Animal experimentation was carried out in accordance with the 
requirements of Karolinska Institutet, Solna, Sweden (Permission no. N417/10).  
 22 
9 RESULTS AND DISCUSSION 
 
9.1 ANALYSES OF AN EXPRESSED SEQUENCE TAG LIBRARY  
(PAPER I). 
An EST library is constructed to describe genes that are expressed during a specific 
stage of the life cycle of an organism. Briefly, mRNA from a particular species in a 
specific stage of development is isolated, transcribed into cDNA, and sequenced. EST 
analysis is a very cost-effective approach for discovering novel genes and identifying 
different groups of proteins (e.g., those with signal peptides) [106-107]. The T. solium 
library consists of 5760 ESTs with 5551 readable sequences. After conducting base call 
and excluding short sequences and vector sequences, 4674 high quality ESTs were 
saved (GenBank accession numbers GT889435-GT894161). Use of the Phred and 
Phrap methods also identified 1650 unique sequences (Table 1).  
 
Table 1. Summary of T. solium ESTs  
Description Number Percentage 
Total number of sequenced clones 5760  
Total number of successful sequences
 
5551 96.4%
a 
Number of high quality sequences
 
4674 84.2%
b 
Unique sequences
 
1650 35.3%
c 
Number of contigs 434  
Number of clones included in contigs 3462 74.1%
c 
Average clones per contig 7.9  
Number of singletons 1212 25.9% 
Percentages were calculated as the following: proportion of the total of number of ESTs;
a
 proportion of 
successful sequences;
b
 proportion of number of high quality sequences.
c
 
 
Using a BLAST cut-off E-value of 10
–5
, we determined the expression patterns of the 
25 most abundant ESTs. The four sequences expressed most often belong to conserved 
genes found in eukaryotes, which encode the antioxidant enzyme PHGPx, the structural 
proteins tubulin and actin, and a lysosomal enzyme identified as ATPase. This analysis 
also revealed high expression of genes that have been proposed to be expressed on the 
membranes of oncospheres and involved in establishment of this larval stage in 
humans.  
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These genes include those that encode Tso31d [108], T24 [97], and H    Tsol18 [89], 
of which the protein Tso118 is a promising candidate for development of a vaccine 
(Table 2) [109-110].   
 
One of the highly expressed sequences showed homology to the 45W family of 
antigens, which are known to be expressed at the surface of the oncosphere [111]. The 
protein Tsol15 (contig 492) was found to have an open reading frame corresponding to 
a protein with a predicted molecular weight of 15.3 kDa. The similarities between 
Tsol15 and T. ovis 45W antigens was demonstrated using a BLAST research option 
with an E-value of < 10
–6
. Other Tsol proteins have been suggested to be valuable 
target molecules for diagnostic and immunization purposes, and Tsol15 may well be 
regarded as a potential diagnostic antigen.  
 
Among the predicted secreted proteins, we also found two different proteinase 
inhibitors. One of these was a serine proteinase inhibitor and the other a Kunitz type 8 
proteinase inhibitor; both these proteins have been identified in the cestode 
Echinococcus granulosus and have been suggested to be involved in the parasite-host 
interface. Putative roles of these proteins are to participate in immunomodulation of the 
host or to function in and interfere with host physiological processes during the initial 
stage of infection [112-113].   
 
The T. solium EST library can also be used to identify new drug targets to treat NCC 
patients. To enable suggestion of new drug targets, 60 different metabolic pathways 
have been annotated and mapped, and these include 6-phosphofructokinase, glutathione 
synthetase, and thioredoxin glutathione reductase [114].   
 
Thus EST libraries can be used to make predictions and to identify genes that might be 
important for discovering novel drugs or developing new diagnostic tools. 
Nevertheless, the results presented in the literature indicate that the functions of the vast 
majority of ESTs identified to date are still unknown. 
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Table 2. Summary of the 25 most abundant ESTs and their putative identity. 
Contig Putative identity (BLASTX) 
 
 
 
Length 
(nt) 
No. of 
ESTs 
Percentage 
of high 
quality 
sequences. 
Identified 
in other 
T. solium 
EST 
libraries  
Poly-
A tail 
identi
-fied 
476 gi|189235991|ref|XP_972419.2|PREDI
CTED: similar to DNA-J, putative  
1012 17 0.36% + - 
477 gi|188485737|gb|ACD50951.1|Nc-
DigChim-324430 [synthetic construct] 
1120 20 0.43% + - 
478* gi|59709858|gb|AAW88559.1|oncosphe
re protein Tso31d [Taenia solium] 
1011 21 0.45% + + 
479 gi|149364041|gb|ABR24229.1|gycerald
ehyde-3-phosphate dehydrogenase 
[Taenia solium] 
1182 21 0.45% + + 
480 Unknown 6 851 21 0.45% + - 
481 gi|37778984|gb|AAP20152.1|alpha-
actin protein [Pagrus major] 
931 22 0.47% + + 
482 gi|221113094|ref|XP_002155286.1|PRE
DICTED: similar to Annexin-B12   
1167 24 0.51% + + 
483 gi|116687782|gb|AAT74668.2|cysteine-
rich secreted protein 2 precursor  
878 24 0.51% + + 
484 Unknown 5 667 25 0.53% + + 
485 Unknown 4 1086 28 0.60% + - 
486 Unknown 3 767 29 0.62% + + 
487 Unknown 2 442 30 0.64% + + 
488 gi|13539680|gb|AAK29203.1|AF22590
5_1ribosomal protein S15a [Taenia 
solium]  
982 34 0.75% + + 
489 dbj|AB086256.1| Taenia solium 
mitochondrial DNA 
983 35 0.75% + + 
490 Unknown 1 991 37 0.79% + + 
491* gi|158934366|emb|CAO82075.1|HP6 
protein [Taenia solium] 
1111 39 0.83% + - 
492* gi|2114399|gb|AAC47532.1|45W 
antigen ToW5/7 [Taenia ovis]/Tsol15 
1088 40 0.86% + + 
493 gi|56753429|gb|AAW24918.1|SJCHGC
05540 protein [Schistosoma japonicum]  
965 58 1.24% + - 
494 gi|37786712|gb|AAP47268.1| 
t24[Taenia solium] 
817 69 1.48% + - 
495 gi|256050212|ref|XP_002569521.1|hyp
othetical protein [Schistosoma mansoni]  
813 70 1.50% + + 
496 dbj|AB086256.1| Taenia solium 
mitochondrial DNA 
1235 74 1.58% + - 
497* gb|AAH30393.1| ATPase, H+ 
transporting, lysosomal V0 subunit B  
803 99 2.12% + - 
498 dbj|BAD88768.1|  tubulin  1865 143 3.12% + + 
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499 gi|207298859|gb|ACI23578.1|beta-actin  1251 214 4.58% + + 
500 gi|117956206|gb|ABK58679.1|PHGPx 
isoform 1 
1359 414 8.86% + + 
BLASTX was used with an E-value cut-off of < 10
–5
.  *Putative signal peptide. 
 
 
9.2 IDENTIFICATION OF IMMUNOGENIC PROTEINS (PAPER II) 
Identification of recombinant antigens for human cysticercosis can lead to easily 
obtained, low-cost substitutes for the native antigens, as well as a reproducible, field-
applicable diagnostic assay [70]. At present, T. solium antigens for diagnosis of human 
cysticercosis are derived from parasites extracted from infected pork [4]. 
 
The main objective of the study reported in Paper II was to identify antigenic proteins 
and evaluate their potential in human NCC. Six immunoreactive proteins were 
identified by 2-DE Western blotting and sequenced by LC-MSMS. These antigens 
included phosphoenolpyruvate carboxykinase, 14-3-3 protein from Echinococcus. 
multilocularis, actin, paramyosin, the small heat shock protein TsolHSP36 [104, 115-
117], and the novel protein Tsol-p27 (Fig. 3).  
 
 Figure 3. Identification of immunoreactive proteins from T. solium cysticerci by 2-DE Western blot 
analysis. Total protein was extracted from cysticerci and loaded in the first dimension. Molecular size 
(kDa) is indicated to the left, and the designated proteins (arrows and numbers) were analysed by LC-
MSMS. (A) A 2-DE gel stained with Coomassie Brilliant Blue. (B) A Western blot of sera from patients 
with NCC. (C) A Western blot of sera from a control group of NCC-negative individuals from the same 
area as the patients who provided the serum in panel B. 
 
Tsol-p27 and TsolHSP36 were selected for recombinant production and preliminary 
serological evaluation. The other four immunoreactive proteins that were identified 
were not subjected to further study due to their conserved nature, and because they are 
present in other parasite-related species determined by a previous BLAST search 
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(NCBI). A cut-off E-value of 1 e
–5
 was used to exclude irrelevant or low BLAST 
scores.  
 
Sequencing alignment of Tsol-p27 showed homology with the antigenic protein P-29 
previously identified in E. granulosus [118]. P-29 is expressed in the larval stage of that 
species and is considered to be a suitable protein for immunodiagnosis of CE in 
humans [119].    
 
To be able to compare the immunogenicity of Tsol-p27 with that of TsolHSP36 [104], 
it was also necessary to clone and express the latter protein. TsolHSP36 has previously 
been described as a target antigen in the diagnosis of human NCC [104].  
 
Western blot analysis of Tsol-p27 recombinant antigen was carried out using 13 serum 
samples from NCC-positive patients and 13 from NCC-negative subjects. TsolHSP36 
was recognized by only two of the positive samples, whereas Tsol-p27 was recognized 
by all 13 positive samples. None of the proteins were recognized by sera from the 
NCC-negative group. Even though the number of serum samples evaluated in this 
study was limited, the results indicate that Tsol-p27 might be a suitable candidate for 
diagnosis of human NCC 
 
9.3 EVALUATION OF AN IMMUNODOT BLOT ASSAY USING TSOL-P27 
 (PAPER III) 
The immunodiagnostic methods that are currently available for diagnosing human 
cysticercosis are specific and sensitive. However, they also have the disadvantage of 
requiring expensive and specialized equipment that must be run by specially trained 
technicians. Another potential drawback is that T. solium antigens for diagnosis of 
human cysticercosis are derived from parasites extracted from infected pork, which 
might decrease the sensitivity and specificity of the tests [4].  
 
In this study (Paper II), Tsol-p27 antigen was identified in T. solium cysticercus extract 
by 2-DE Western blotting using human sera confirmed to be positive for NCC. To 
obtain a cheap diagnostic method that is easy to perform in poorly equipped 
laboratories, we developed and validated an immunodot blot assay using the 
recombinant Tsol-p27 antigen. To increase the efficacy and reduce the background, we 
purified the Tsol-p27 in two steps using glutathione-agarose and his-selected nickel 
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beads. The results obtained using our immunodot blot technique with the highly 
purified Tsol-p27 antigen showed a markedly decreased background compared to what 
could be achieved by Western blot analysis using one-step purified Tsol-p27 antigen. 
Figure 4 shows the Tsol-p27 antigen in SDS-PAGE, visualized by staining with 
Coomassie Brilliant Blue.  
 
 
Figure 4. SDS-PAGE analysis of Tsol-p27 antigen. Lane 1, cells from induced E. coli; lane 2, purified 
recombinant GST/Tsol-p27; lane 3, Tsol-p27 digested with precision protease; lane 4, Tsol-p27 after 
purification using glutathione-agarose and his-selected nickel magnetic beads.  
 
In order to evaluate the immunodot blot Tsol-p27 test, a commercial ELISA and the 
antigen TsolHSP36 and Tsol-p27 in Western blot formats were included in the 
serological evaluation. The EITB results were regarded as confirmatory of human 
cysticercosis and used as a standard to assess the performance of the diagnostic 
methods [71].  
 
The sensitivity and specificity values were determined based on the positive and 
negative results obtained by EITB analysis. Of the 100 investigated serum samples 
from epileptic patients, 13 were positive and 87 negative by EITB. Table 3 summarizes 
the performance of the different immunodiagnostic tests in comparison with EITB as 
the gold standard method for detection of antibodies in serum from epileptic patients. 
 
The immunodot blot Tsol-p27 test was comparable to the Western blot Tsol-p27 assay 
with respect to specificity (97.8% versus 95.6%) but not sensitivity (86.7 versus 
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76.4%), and it was similar to ELISA regarding both specificity (97.8% versus 94.6%) 
and sensitivity (86.7 versus 86.7). Western blot TsolHSP36 showed lower specificity 
(86.1%) and sensitivity (61.9%) compared to the other immunodiagnostic methods. An 
example of the results obtained with the immunodot blot assay using the Tsol-p27 
antigen is presented in Figure 5. 
 
Table 3. Comparison of different immunodiagnostic tests with the EITB method as the gold standard for 
detection of antibodies against T. solium cysticerci in serum samples from epileptic patients 
  EITB 
 Positive Negative Total 
 Immunodot blot Tsol-p27    
 Positive 13 5 18 
 Negative 2 87 89 
 Total 15 92 102 
 Commercial ELISA    
 Positive 13 5 18 
 Negative 2 87 89 
 Total 15 92 102 
 Western blot Tsol-p27    
 Positive 13 4 17 
 Negative 1 87 88 
 Total 14 91 105 
 Western blot TsolHSP36    
 Positive 13 14 27 
 Negative 8 87 95 
 Total 21 101 122 
 
It has been reported that using ELISA to detect specific antibodies against T. solium 
cysticerci in samples from patients with suspected cysticercosis provides a useful tool 
for diagnosis of this disease [120]. However, the results of ELISA employed for this 
purpose vary significantly [36, 121], and the discrepancy between studies can be 
explained by the use of disparate criteria for patient selection and different methods as 
the gold standard.  
 
The immunodot blot Tsol-p27 test showed good sensitivity and specificity in our study, 
and it is simpler to perform and less expensive than ELISA, EITB, and Western blot 
analysis. In addition, the immunodot blot method can be easily implemented in poorly 
equipped laboratories in endemic countries. 
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Figure 5. Immunodot blot analysis using the Tsol-p27 antigen. (A) Probing done with sera from two 
NCC -positive controls (1 and 2), seven positive epileptic cases (3–9), and two negative controls (10 and 
11). (B) Probing done with negative serum samples from epileptic cases. (C) Probing done with sera from 
patients positive (1–6) or negative (7–11) for Chagas disease. 
 
9.4 LOCALIZATION OF THE PROTEINS TSOL-P27 AND TSOLHSP36 IN 
T. SOLIUM CYSTICERCUS (PAPER IV) 
Recombinant antigens have been tested because they show potential for diagnosing 
human cysticercosis, and the recombinant proteins Tsol-p27 and TsolHSP36 show 
considerable promise in that context [6, 104]. Nevertheless, no data have been 
published regarding the localization of Tsol-p27 and TsolHSP36 in the T. solium 
cysticercus or the biological function of Tsol-p27. In our study (Paper IV), antibodies 
against Tsol-p27 and TsolHSP36 were produced in rabbits and used to analyse 
localization of these proteins in T. solium.  
 
Antisera were found to contain antibodies specific to their respective antigens. In 
Western blot analysis, Tsol-p27 was detected in both the cysticercal and the adult stage, 
revealed as a single 27-kDa band, whereas TsolHSP36 protein was detected only in the 
cysticercus as a single 36-kDa band (Fig. 6).  
 
Immunohistochemistry analysis revealed that Tsol-p27 and TsolHSP36 were reactive 
in the spiral canal and tegument of the T. solium cysticercus (Fig. 7). The presence of 
Tsol-p27 in the spiral canal may be related to growth and support of an adult tapeworm 
in the human intestine. Furthermore, Tsol-p27 may contribute to attachment of the 
scolex to the host’s intestinal wall, where it must remain despite the strong peristaltic 
action of the intestine. The reaction of the parasite tegument to Tsol-p27 suggests that 
this protein is involved in the ability of the worm to absorb nutrients from the host 
[122-123]. 
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Figure 6. Western blot analysis of extracts of cysticercal (A) and adult (B) T. solium tissue using anti- 
rabbit Tsol-p27, TsolHSP36, and pre-immune sera. Lane 1 was probed with anti-rabbit Tsol-p27 serum, 
and lane 2 with pre-immune serum, lane 3 with anti-rabbit TsolHSP36 serum, and lane 4 with pre-
immune serum.  
 
Sequencing analysis of Tsol-p27 using a cut-off value of < 10
–9
 revealed an endophilin-
B BAR domain. Members of this group of proteins are involved in clathrin-mediated 
endocytosis, binding to membrane vesicles, and induction of tubular conformation. 
These biological processes are associated with the endoplasmic reticulum, Golgi 
apparatus, and endocytic vesicles, where they are important for a variety of processes 
that require membrane sorting [124-125]. 
 
Figure 7. Sections of T. solium cysticerci photographed under phase contrast and an FITC filter. Panels A 
and D illustrate (arrows) the parenchymal folds (PF) and tegument of the spiral canal (TSC); panels B 
and E are images obtained using rabbit anti-Tsol-p27 and anti-TsolHSP36 proteins, with structures 
indicated as in A and D; panels C and F show results obtained with the  pre-immune sera used as 
controls. Scale bars: 100 µm in panel A and 200 µm in panels B, C, D, E and F. 
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A phylogenetic tree was constructed to determine relationships between BAR regions 
of endophilin-B proteins from different species (Fig. 8). This analysis indicated that 
Tsol-p27 from T. solium was more closely related to the BAR region from S. 
japonicum than to other BAR regions within the group. Both these parasitic species 
belong to the phylum Platyhelminthes or flatworms. 
 
Figure 8. Phylogenetic tree based on sequences of the endophilin-B protein. The multiple sequence 
alignments were obtained using ClustalW, and the tree was constructed with the software Lasergene 9 
(DNASTAR. Inc., WI., USA). Bootstrap values from 1,000 replicates were used to assess the robustness 
of the generated tree. 
 
The responses involving HSPs represent a general homeostatic mechanism that protects 
cells and organisms from damage caused by environmental stress [126-127]. 
TsolHSP36 is present in the T. solium cysticercus, where it is localized to the spiral 
canal and tegument. It is possible that a cysticercus can be exposed to strong variation 
in temperature while in the intermediate host (i.e., before reaching the final host), and it 
is also plausible that the host immune response can play an important role in the 
changes in temperature [126]. The presence of TsolHSP36 in the larval stage suggests 
that it is involved in promoting survival of the parasite by protecting it from the harsh 
environment.   
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10 CONCLUSIONS 
 
Paper I: More than half of the sequences analysed in the EST library were of unknown 
function, and 845 novel sequences were identified. EST analysis is a very cost-effective 
method for discovering new genes and identifying different groups of proteins.  
 
Paper II: Tsolp-27 and TsolHSP36 were identified and serologically evaluated. 
Results of Western blot analysis indicated that Tsol-p27 is a better antigen than 
TsolHSP36, and thus Tsol-p27 might be tested and evaluated as a suitable candidate for 
diagnosing human NCC.  
 
Paper III: The immunodot blot Tsol-p27 assay performed well compared to other 
diagnostic tests. This method is simpler to use and less expensive than ELISA, EITB, 
and Western blot analysis. It would be easy to implement the immunodot blot Tsol-p27 
test in poorly equipped laboratories in low-income countries. 
 
Paper IV: The function of Tsol-p27 might be related to a variety of biological 
processes that involve membrane sorting, fusion, and transport, and it might also aid 
and promote the growth of the adult tapeworm within the human intestine. 
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